Zosano Pharma Corporation (ZSAN) Stock Balance Sheet
NASDAQ:ZSAN - Nasdaq - US98979H3012 - Common Stock
| MRQ (2022-3-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 13.53M | 11.04M | 35.26M | 6.32M | 9.14M | |||
| Marketable Securities | N/A | N/A | N/A | 0.00 | 13.86M | |||
| Receivables | 110.00K | 150.00K | 120.00K | N/A | N/A | |||
| Other Current Assets | 1.99M | 420.00K | 330.00K | 500.00K | 360.00K | |||
| Total Current Assets | 15.63M | 11.61M | 35.72M | 6.81M | 23.36M | |||
| Non-Current Assets | ||||||||
| PPE Net | 10.36M | 36.33M | 35.84M | 30.40M | 11.92M | |||
| Other Non-Current Assets | 460.00K | 460.00K | 460.00K | 460.00K | 500.00K | |||
| Total Non-Current Assets | 10.82M | 36.78M | 36.29M | 30.86M | 12.42M | |||
| TOTAL ASSETS | 26.45M | 48.39M | 72.01M | 37.67M | 35.78M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.74M | 3.82M | 5.59M | 4.57M | 2.33M | |||
| Accrued Expenses | 3.64M | 4.96M | 6.93M | 7.31M | 4.51M | |||
| Accounts Payable | 3.72M | 2.12M | 1.88M | 4.36M | 4.45M | |||
| Other Current Liabilities | 630.00K | 230.00K | 110.00K | N/A | N/A | |||
| Total Current Liabilities | 9.73M | 11.13M | 14.51M | 16.24M | 11.29M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | N/A | 970.00K | 5.17M | 6.11M | 4.50M | |||
| Other Non-Current Liabilities | 2.66M | 3.31M | 4.81M | 5.93M | 1.29M | |||
| Total Non-Current Liabilities | 2.66M | 4.28M | 9.99M | 12.04M | 5.78M | |||
| TOTAL LIABILITIES | 12.39M | 15.41M | 24.50M | 28.28M | 17.07M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -395.52M | -362.12M | -332.19M | -298.82M | -261.23M | |||
| Additional Paid In Capital | 409.58M | 395.08M | 379.70M | 308.21M | 279.95M | |||
| Common Shares | N/A | 10.00K | 10.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 0.00 | N/A | N/A | 0.00 | -10.00K | |||
| Shares Outstanding | 4.90M | 3.43M | 102.07M | 23.50M | 11.97M | |||
| Tangible Book Value per Share | N/A | 9.60 | 0.47 | 0.40 | 1.56 | |||
| Total Shareholders' Equity | 14.05M | 32.98M | 47.52M | 9.39M | 18.71M | |||
| TOTAL LIABILITIES AND EQUITY | 26.45M | 48.39M | 72.01M | 37.67M | 35.78M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.03 | 0.11 | 0.65 | 0.24 | |||
| Current Ratio | 1.61 | 1.04 | 2.46 | 0.42 | 2.07 | |||
| Return On Assets (ROA) | -208.66% | -61.85% | -46.34% | -99.79% | -98.83% | |||
| Return On Equity (ROE) | -392.81% | -90.75% | -70.22% | -400.32% | -188.99% | |||
All data in USD , ROIC based on taxRate of 0.21